7-128851549-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001458.5(FLNC):​c.5763T>C​(p.Thr1921Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0813 in 1,613,870 control chromosomes in the GnomAD database, including 14,730 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T1921T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.18 ( 5273 hom., cov: 33)
Exomes 𝑓: 0.071 ( 9457 hom. )

Consequence

FLNC
NM_001458.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -6.58

Publications

18 publications found
Variant links:
Genes affected
FLNC (HGNC:3756): (filamin C) This gene encodes one of three related filamin genes, specifically gamma filamin. These filamin proteins crosslink actin filaments into orthogonal networks in cortical cytoplasm and participate in the anchoring of membrane proteins for the actin cytoskeleton. Three functional domains exist in filamin: an N-terminal filamentous actin-binding domain, a C-terminal self-association domain, and a membrane glycoprotein-binding domain. Mutations in this gene are a cause of cardiopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2022]
FLNC-AS1 (HGNC:53474): (FLNC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 7-128851549-T-C is Benign according to our data. Variant chr7-128851549-T-C is described in ClinVar as Benign. ClinVar VariationId is 129094.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.58 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.465 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLNCNM_001458.5 linkc.5763T>C p.Thr1921Thr synonymous_variant Exon 35 of 48 ENST00000325888.13 NP_001449.3
FLNCNM_001127487.2 linkc.5664T>C p.Thr1888Thr synonymous_variant Exon 34 of 47 NP_001120959.1
FLNC-AS1NR_149055.1 linkn.216-49A>G intron_variant Intron 2 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLNCENST00000325888.13 linkc.5763T>C p.Thr1921Thr synonymous_variant Exon 35 of 48 1 NM_001458.5 ENSP00000327145.8

Frequencies

GnomAD3 genomes
AF:
0.182
AC:
27646
AN:
152124
Hom.:
5263
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.470
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.129
Gnomad ASJ
AF:
0.0161
Gnomad EAS
AF:
0.352
Gnomad SAS
AF:
0.184
Gnomad FIN
AF:
0.0214
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0428
Gnomad OTH
AF:
0.139
GnomAD2 exomes
AF:
0.125
AC:
31322
AN:
250952
AF XY:
0.116
show subpopulations
Gnomad AFR exome
AF:
0.473
Gnomad AMR exome
AF:
0.163
Gnomad ASJ exome
AF:
0.0183
Gnomad EAS exome
AF:
0.361
Gnomad FIN exome
AF:
0.0265
Gnomad NFE exome
AF:
0.0439
Gnomad OTH exome
AF:
0.0910
GnomAD4 exome
AF:
0.0709
AC:
103562
AN:
1461628
Hom.:
9457
Cov.:
34
AF XY:
0.0720
AC XY:
52344
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.478
AC:
16006
AN:
33480
American (AMR)
AF:
0.161
AC:
7184
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0183
AC:
477
AN:
26136
East Asian (EAS)
AF:
0.334
AC:
13250
AN:
39700
South Asian (SAS)
AF:
0.167
AC:
14424
AN:
86258
European-Finnish (FIN)
AF:
0.0276
AC:
1467
AN:
53176
Middle Eastern (MID)
AF:
0.0531
AC:
306
AN:
5768
European-Non Finnish (NFE)
AF:
0.0403
AC:
44865
AN:
1111996
Other (OTH)
AF:
0.0924
AC:
5583
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
5896
11793
17689
23586
29482
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2148
4296
6444
8592
10740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.182
AC:
27684
AN:
152242
Hom.:
5273
Cov.:
33
AF XY:
0.181
AC XY:
13449
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.470
AC:
19512
AN:
41506
American (AMR)
AF:
0.128
AC:
1964
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0161
AC:
56
AN:
3468
East Asian (EAS)
AF:
0.351
AC:
1815
AN:
5166
South Asian (SAS)
AF:
0.183
AC:
884
AN:
4828
European-Finnish (FIN)
AF:
0.0214
AC:
228
AN:
10630
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0428
AC:
2914
AN:
68022
Other (OTH)
AF:
0.139
AC:
293
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
903
1805
2708
3610
4513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0766
Hom.:
2530
Bravo
AF:
0.203
Asia WGS
AF:
0.272
AC:
943
AN:
3478
EpiCase
AF:
0.0402
EpiControl
AF:
0.0443

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:9
Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 29, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Jan 13, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Thr1921Thr in exon 35 of FLNC: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 46.2% (2036/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequ encing Project (http://evs.gs.washington.edu/EVS; dbSNP rs3816884).

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Dec 13, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
Dec 24, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.038
DANN
Benign
0.37
PhyloP100
-6.6
Mutation Taster
=80/20
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3816884; hg19: chr7-128491603; COSMIC: COSV57957802; API